Advertisement
Advertisement
U.S. Markets close in 2 hrs 35 mins
Advertisement
Advertisement
Advertisement
Advertisement

Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ.DE)

XETRA - XETRA Delayed Price. Currency in EUR
55.65+2.00 (+3.73%)
At close: 05:35PM CET
Advertisement

Eckert & Ziegler Strahlen- und Medizintechnik AG

Robert-Rössle-Strasse 10
Berlin 13125
Germany
49 30 94 10 84 0
https://www.ezag.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees957

Key Executives

NameTitlePayExercisedYear Born
Dr. Andreas Eckert Ph.D.Chairman of Exec. Board & CEO340.75kN/A1960
Dr. Harald HasselmannHead of Radiation Therapy Segment & Member of the Exec. Board - Medical Segment258.56kN/A1967
Dr. Lutz HelmkeMember of Exec. Board - Medical Segment254.19kN/A1961
Dr. Gunnar MannHead of Intragroup ServicesN/AN/A1967
Mr. Franklin B. YeagerPres of Eckert & Ziegler Isotope Products Inc.N/AN/AN/A
Mr. Joseph HathcockVP of Eckert & Ziegler Isotope Products IncN/AN/AN/A
Ivan SimmerManaging Director of Eckert & Ziegler Cesio s.r.o.N/AN/AN/A
Ms. Claudia GoulartMD - Eckert & Ziegler Brasil Participacoes, Comericial & Logistica Ltda.N/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.

Corporate Governance

Eckert & Ziegler Strahlen- und Medizintechnik AG’s ISS Governance QualityScore as of October 1, 2022 is 9. The pillar scores are Audit: 9; Board: 9; Shareholder Rights: 1; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement